Business Context and Reporting Period
This Form 8-K Current Report was filed by Zimmer Biomet Holdings, Inc. on March 13, 2020. The filing discloses the entry into a material definitive agreement regarding a public offering of senior notes.
Key Financial Metrics and Transaction Details
The Company entered into an underwriting agreement to issue the following debt securities:
- 2026 Notes: $600.0 million aggregate principal amount at an interest rate of 3.050% per annum, maturing January 15, 2026.
- 2030 Notes: $900.0 million aggregate principal amount at an interest rate of 3.550% per annum, maturing March 20, 2030.
- Total Proceeds: $1.5 billion aggregate principal amount.
- Closing Date: Scheduled for March 20, 2020, subject to customary conditions.
The filing does not provide specific values for revenue, profit, cash flow, operating margins, or current liquidity ratios. It notes the existence of $1.5 billion in outstanding 2.700% Senior Notes due 2020.
Material Changes and Use of Proceeds
The primary material change is the expansion of the Company's debt capital structure through the issuance of the new Notes. The filing indicates that the Company intends to use the net proceeds from this offering to:
- Repay the outstanding $1.5 billion aggregate principal amount of 2.700% Senior Notes due 2020 at maturity.
- Pay related transaction fees and expenses.
- Provide for general corporate purposes.
Guidance, Risks, and Contingencies
Management Commentary: The transaction is structured under a seventh supplemental indenture to the Base Indenture dated November 17, 2009. The underwriters include BofA Securities, Inc., Citigroup Global Markets Inc., RBC Capital Markets, LLC, and Wells Fargo Securities, LLC.
Risks and Contingencies:
- Closing Risk: The offering is subject to customary closing conditions and may not be consummated on anticipated terms.
- Forward-Looking Statements: The report contains forward-looking statements regarding the closing and use of proceeds, which are subject to significant risks and uncertainties.
- Underwriter Relationships: Some underwriters and their affiliates have existing commercial banking and lending relationships with the Company. Additionally, underwriters holding the 2020 Notes would receive their proportionate share of proceeds used to repay those notes.
Investor Verification Checklist
- Verify the final closing of the $1.5 billion note offering on or around March 20, 2020.
- Confirm the exact net proceeds received after deducting underwriting discounts and transaction expenses.
- Monitor the repayment of the $1.5 billion 2020 Notes at maturity to ensure the refinancing is executed as planned.
- Review the definitive Underwriting Agreement (Exhibit 1.1) for specific covenants and indemnification terms.